The "Europe Immunochemistry Market to 2027 Regional Analysis and Forecasts by Application; Product; End User, and Country" report has been added to ResearchAndMarkets.com's offering.
The Europe immunochemistry market is expected to reach US $775.97 Mn in 2027 from US $430.82 Mn in 2018. The market is estimated to grow with a CAGR of 6.9% from 2019-2027.
The growth of the immunochemistry market is primarily attributed to the significantly increasing prevalence of cardiovascular diseases and rising incidence of diabetes in the region. However, shortage of skilled professionals is likely to have a negative impact on market growth. On the other hand, rising healthcare expenditure in Europe is likely to have a positive impact on the growth of the Europe immunochemistry market in the coming years.
The growth of the immunochemistry market is primarily attributed to the significantly increased prevalence of cardiovascular diseases and the rising incidence of diabetes in the region. However, a shortage of skilled professionals is likely to have a negative impact on market growth. On the other hand, rising healthcare expenditure in Europe is expected to have a positive impact on the growth of the European immunochemistry market in the coming years.
As per the data estimated by the European Cardiovascular Disease Statistics 2017, cardiovascular disease (CVD) causes 3.9 million deaths and more than 1.8 million deaths in Europe every year. The CVD accounts for 45.0% of all deaths in Europe and 37.0% of all deaths in the EU. CVD is the primary reason for the death of men and women in all countries. Furthermore, as per the American Heart Association (AHA) 2019 statistics, 121.5 million adults in the U.S. which are around half of the US adult population, suffer from cardiovascular disease.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe immunochemistry market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe immunochemistry market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Key Topics Covered:
1. Introduction
2. Europe Immunochemistry Market- Key Takeaways
3. Research Methodology
4. Europe Immunochemistry Market Market Landscape
4.1 Overview
4.2 Market Segmentation
4.2.1 Europe Immunochemistry Market By Product
4.2.2 Europe Immunochemistry Market By Application
4.2.3 Europe Immunochemistry Market By End User
4.2.4 Europe Immunochemistry Market By Country
4.3 PEST Analysis
5. Europe Immunochemistry Market Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Significantly Increasing Prevalence of Cardiovascular Diseases
5.1.2 Rising Incidence of Diabetes
5.2 Key Market Restraints
5.2.1 Shortage of Skilled Professionals
5.3 Key Market Opportunities
5.3.1 Rising Healthcare Expenditure in Europe
5.4 Future Trends
5.4.1 Rising Future Conferences and Workshops
5.5 Impact Analysis
6. Immunochemistry Market Europe Analysis
6.1 Europe Immunochemistry Market Revenue Forecasts And Analysis
6.2 Performance of Key Players
7. Europe Immunochemistry Market Analysis By Application
7.1 Overview
7.2 Europe Immunochemistry Market, By Application, 2018 2027 (%)
7.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
7.4 Diagnostics
7.5 Drug Testing
8. Europe Immunochemistry Market Analysis By Product
8.1 Overview
8.2 Europe Immunochemistry Market, By Product, 2018 2027 (%)
8.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.4 Antibodies Market
8.5 Equipment
8.6 Reagents
8.7 Kits
9. Europe Immunochemistry Market Analysis By End User
9.1 Overview
9.2 Europe Immunochemistry Market, By End User, 2018 2027 (%)
9.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4 Hospital Diagnostic Laboratories
9.5 Research Institutes
9.6 Others End Users
10. Europe Immunochemistry Market Revenue and Forecasts To 2027
11. Immunochemistry Market Industry Landscape
11.1 Overview
11.2 Growth Strategies done by the companies in the Market, 2018 (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic developments
11.4.1 Overview
12. Immunohistochemistry Market-Key Company Profiles
12.1 Bio SB
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Cell Signaling Technology, Inc.
12.3 F. Hoffmann-La Roche Ltd.
12.4 Merck KGaA
12.5 PerkinElmer, Inc.
12.6 Thermo Fisher Scientific, Inc.
12.7 Abcam Plc.
12.8 Agilent Technologies, Inc.
12.9 Bio-Rad Laboratories, Inc.
12.10 Danaher
13. Appendix
13.1 About the Publisher
13.2 Glossary Of Terms
For more information about this report visit https://www.researchandmarkets.com/r/sca8xj
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200414006103/en/
Contacts:
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
